| Technique | 3D CRT (%) | VMAT (%) | P-value* |
| Epistaxis pre-treatment | 2 (8.3%) | 10 (41.6%) | p = 0.5 |
| Epistaxis post-treatment | 0 (0%) | 2 (8.3) | |
| Nasal obstruction pre-treatment | 9 (37.5%) | 15 (62.5%) | p ≤ 0.012 |
| Nasal obstruction post-treatment | 0 (0%) | 3 (12.5%) |